Schedule 13D ownership disclosure

NovaBay Pharmaceuticals Inc

Common Stock, par value $0.01 per share · CUSIP: 66987P409

Event date: 2025-10-20

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Poplar Point Capital Management LLCReported CIK 0001588273

    Shares: 1,020,300.00 · Class: 0.81%

  • Poplar Point Capital Partners LPReported CIK 0001588289

    Shares: 1,020,300.00 · Class: 0.81%

  • Poplar Point Capital GP LLCReported CIK 0001588288

    Shares: 1,020,300.00 · Class: 0.81%

  • Jad FakhryReported CIK 0001588217

    Shares: 1,020,300.00 · Class: 0.81%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001398344-26-005034
Form type
SCHEDULE 13D/A
Filer
Stablecoin Development Corp
CIK
CIK 1389545
Filed
Mar 11, 2026
Reporting period
Oct 20, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub